Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ganz

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Maternal and Child Health Journal|December 6, 2005
Continuity of health insurance coverage for children with special health care needsChia-Ling Liu, Alan M Zaslavsky, Michael L Ganz, et al.
Current Medical Research and Opinion|July 22, 2015
The dynamic relationship between current and previous severe hypoglycemic events: a lagged dependent variable analysis among patients with type 2 diabetes who have initiated basal insulinMichael L Ganz, Qian Li, Neil S Wintfeld, et al.
Hospital Practice (1995)|August 2, 2018
Economic burden of hospital admissions for patients with acute bacterial skin and skin structure infections in the United StatesKatelyn R Keyloun, David J Weber, Betsey M Gardstein, et al.
Current Medical Research and Opinion|June 20, 2014
Severe hypoglycemia rates and associated costs among type 2 diabetics starting basal insulin therapy in the United StatesMichael L Ganz, Neil S Wintfeld, Qian Li, et al.
American Journal of Epidemiology|March 3, 1998
Contribution of smoking to excess mortality in HarlemM E Northridge, A Morabia, M L Ganz, et al.
Journal of Medical Economics|July 27, 2017
Reply: Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United StatesCatherine Saint-Laurent Thibault, Divya Moorjaney, Michael L Ganz, et al.
Journal of Medical Economics|March 16, 2017
Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United StatesCatherine Saint-Laurent Thibault, Divya Moorjaney, Michael L Ganz, et al.
Applied Health Economics and Health Policy|June 29, 2019
Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian AdultsAshleigh McGirr, Desiree Van Oorschot, Robyn Widenmaier, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 23, 2020
Oral Corticosteroid Treatment Patterns of Patients in the United States with Persistent AsthmaTrung N Tran, Sharon MacLachlan, Wesley Hicks, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 1, 2022
Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database StudyAmit D Raval, Michael L Ganz, Kathy Fraeman, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Maternal and Child Health Journal|December 6, 2005
Continuity of health insurance coverage for children with special health care needsChia-Ling Liu, Alan M Zaslavsky, Michael L Ganz, et al.
Current Medical Research and Opinion|July 22, 2015
The dynamic relationship between current and previous severe hypoglycemic events: a lagged dependent variable analysis among patients with type 2 diabetes who have initiated basal insulinMichael L Ganz, Qian Li, Neil S Wintfeld, et al.
Hospital Practice (1995)|August 2, 2018
Economic burden of hospital admissions for patients with acute bacterial skin and skin structure infections in the United StatesKatelyn R Keyloun, David J Weber, Betsey M Gardstein, et al.
Current Medical Research and Opinion|June 20, 2014
Severe hypoglycemia rates and associated costs among type 2 diabetics starting basal insulin therapy in the United StatesMichael L Ganz, Neil S Wintfeld, Qian Li, et al.
American Journal of Epidemiology|March 3, 1998
Contribution of smoking to excess mortality in HarlemM E Northridge, A Morabia, M L Ganz, et al.
Journal of Medical Economics|July 27, 2017
Reply: Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United StatesCatherine Saint-Laurent Thibault, Divya Moorjaney, Michael L Ganz, et al.
Journal of Medical Economics|March 16, 2017
Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United StatesCatherine Saint-Laurent Thibault, Divya Moorjaney, Michael L Ganz, et al.
Applied Health Economics and Health Policy|June 29, 2019
Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian AdultsAshleigh McGirr, Desiree Van Oorschot, Robyn Widenmaier, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 23, 2020
Oral Corticosteroid Treatment Patterns of Patients in the United States with Persistent AsthmaTrung N Tran, Sharon MacLachlan, Wesley Hicks, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 1, 2022
Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database StudyAmit D Raval, Michael L Ganz, Kathy Fraeman, et al.
Pageof 9